2|0|Public
50|$|<b>Panadiplon</b> {{acts as a}} high-affinity GABAA {{receptor}} partial agonist, {{but despite}} showing a useful effects profile of a potent anxiolytic with little sedative effects, <b>panadiplon</b> was discontinued from clinical development for use in humans after showing evidence of liver damage in both animals and human trials. <b>Panadiplon</b> however continues {{to be used in}} animal research, mainly as a subtype-selective reference drug to compare other GABAA agonists against.|$|E
50|$|<b>Panadiplon</b> (U-78875) is an {{anxiolytic}} drug {{with a novel}} {{chemical structure}} that is not closely related to other drugs of this type. It has a similar pharmacological profile to the benzodiazepine family of drugs, but with mainly anxiolytic properties and relatively little sedative or amnestic effect, and so is classified as a nonbenzodiazepine anxiolytic.|$|E

